title: Effects of long-term treatment with montelukast in mild cystic fibrosis (long term treatment with montelukast in cystic fibrosis).
authors.forename: Sabina
authors.initials: S
authors.lastname: Schmitt-Grohé
authors.forename: Olaf
authors.initials: O
authors.lastname: Eickmeier
authors.forename: Christian
authors.initials: C
authors.lastname: Naujoks
authors.forename: Ralph
authors.initials: R
authors.lastname: Schubert
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Lentze
authors.forename: Stefan
authors.initials: S
authors.lastname: Zielen
authors.forename: Ernst
authors.initials: E
authors.lastname: Rietschel
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D000293:Adolescent; D002648:Child; D003521:Cyclopropanes; D003550:Cystic Fibrosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D008134:Long-Term Care / Q000379:methods; D008297:Male; D011804:Quinolines / Q000627:therapeutic use*; D013440:Sulfides; D016896:Treatment Outcome
chemical_list: D000085:Acetates; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast